Plasma-derived microparticles for biomarker discovery

Clinical Laboratory

Volumn 54, Issue 3-4, 2008, Pages 67-79

  Smalley, David M ^a,b,e   Ley, Klaus ^a,b,c,d  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c University of Virginia   (United States)

^d LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^e Biomedical Research Facility   (United States)

Author keywords

Apoptosis; Biomarker discovery; Ectosomes; Exosomes; Microparticles; Proteomics

Indexed keywords

ALBUMIN; ALPHA 1 MICROGLOBULIN; ALPHA 2 MACROGLOBULIN; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN A4; APOLIPOPROTEIN B; ARYLDIALKYLPHOSPHATASE 1; BETA2 GLYCOPROTEIN 1; BIOLOGICAL MARKER; CERULOPLASMIN; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; CONNECTIN; FIBRINOGEN; GELSOLIN; HEMOPEXIN; IMMUNOGLOBULIN; PLASMA PROTEIN; PLASMINOGEN; PREALBUMIN; PREGNANCY ASSOCIATED ALPHA2 GLYCOPROTEIN; PROTEOME; RETINOL BINDING PROTEIN 4; SERINE PROTEINASE INHIBITOR; TRANSFERRIN; VITAMIN D BINDING PROTEIN;

BIOINFORMATICS; BLOOD DISEASE; CARDIOVASCULAR DISEASE; DISEASE MARKER; ENDOSOME; EXOSOME; HUMAN; INFECTION; INFLAMMATORY DISEASE; ISOTOPE LABELING; LIQUID CHROMATOGRAPHY; MEMBRANE VESICLE; METABOLIC DISORDER; MOLECULAR SIZE; NONHUMAN; PARTICLE SIZE; PROTEIN ANALYSIS; PROTEIN STRUCTURE; PROTEOMICS; QUANTITATIVE STUDY; REVIEW; TANDEM MASS SPECTROMETRY;

ANTIGENS, SURFACE; BIOLOGICAL MARKERS; BLOOD PROTEINS; HUMANS; MASS SPECTROMETRY; MICROCHEMISTRY; PLASMA; PROTEOMICS; SECRETORY VESICLES;

EID: 46849121990     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. Cho A, Normile D. Nobel Prize in Chemistry. Mastering macromolecules is misspelled. Science 2002; 298(5593):527-528.
2. Bjorhall K, Miliotis T, Davidsson P. Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics 2005; 5(1):307-317.
3. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999; 20(18): 3551-3567.
4. Eng JK, McCormack AL, Yates JR. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. 1994; 5(11):976.
5. Chernushevich IV, Loboda AV, Thomson BA. An introduction to quadrupole-time-of-flight mass spectrometry. J Mass Spectrom 2001; 36(8):849-865.
6. Peterman SM, Dufresne CP, Horning S. The use of a hybrid linear trap/ FT-ICR mass spectrometer for on-line high resolution/high mass accuracy bottom-up sequencing. J Biomol Tech 2005; 16(2):112-124.
7. Yates JR, Cociorva D, Liao L, Zabrouskov V. Performance of a linear ion trap-Orbitrap hybrid for peptide analysis. Anal Chem 2006; 78(2):493-500.
8. Mikesh LM, Ueberheide B, Chi A, et al. The utility of ETD mass spectrometry in proteomic analysis. Biochim Biophys Acta 2006; 1764(12):1811-1822.
9. Smalley DM, Root KE, Cho H, Ross MM, Ley K. Proteomic discovery of 21 proteins expressed in human plasma-derived but not platelet-derived microparticles. Thromb Haemost 2007; 97(1):67-80.
10. Liu H, Sadygov RG, Yates JR, 3rd. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem 2004; 76(14):4193-4201.
11. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 1999; 17(10):994-999.
12. Ross PL, Huang YN, Marchese JN, et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 2004; 3(12): 1154-1169.
13. Yao X, Freas A, Ramirez J, Demirev PA, Fenselau C. Proteolytic 180 labeling for comparative proteomics: model studies with two serotypes of adenovirus. Anal Chem 2001; 73(13):2836-2842.
14. Ong SE, Blagoev B, Kratchmarova I, et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 2002; 1(5):376-386.
15. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002; 1(11):845-867.
16. Anderson NL, Polanski M, Pieper R, et al. The human plasma proteome: A nonredundant list developed by combination of four separate sources. Mol Cell Proteomics 2004; 3(4):311-326.
17. Hood BL, Zhou M, Chan KC, et al. Investigation of the mouse serum proteome. J Proteome Res 2005; 4(5):1561-1568.
18. Hugel B, Martinez MC, Kunzelmann C, Freyssinet JM. Membrane microparticles: two sides of the coin. Physiology (Bethesda) 2005; 20:22-27.
19. Wolf P. The nature and significance of platelet products in human plasma. Br J Haematol 1967; 13(3):269-288.
20. Horstman LL, Ahn YS. Platelet microparticles: a wide-angle perspective. Crit Rev Oncol Hematol 1999; 30(2):111-142.
21. Nieuwland R, Berckmans RJ, McGregor S, et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 2000; 95(3):930-935.
22. Nomura S, Shouzu A, Omoto S, et al. Effect of cilostazol on soluble adhesion molecules and platelet-derived microparticles in patients with diabetes. Thromb Haemost 1998; 80(3):388-392.
23. Wun T, Paglieroni T, Tablin F, Welborn J, Nelson K, Cheung A. Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia. J Lab Clin Med 1997; 129(5):507-516.
24. Shet AS, Aras O, Gupta K, et al. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood 2003; 102(7):2678-2683.
25. Inoue T, Komoda H, Kotooka N, et al. Increased circulating platelet-derived microparticles are associated with stent-induced vascular inflammation. Atherosclerosis 2007.
26. Simak J, Holada K, Vostal JG. Release of annexin V-binding membrane microparticles from cultured human umbilical vein endothelial cells after treatment with camptothecin. BMC Cell Biol 2002; 3:11.
27. Garcia BA, Smalley DM, Cho H, Shabanowitz J, Ley K, Hunt DF. The platelet microparticle proteome. J Proteome Res 2005; 4(5):1516-1521.
28. Jin M, Drwal G, Bourgeois T, Saltz J, Wu HM. Distinct proteome features of plasma microparticles. Proteomics 2005; 5(7):1940-1952.
29. Reininger AJ, Heijnen HF, Schumann H, Specht HM, Schramm W, Ruggeri ZM. Mechanism of platelet adhesion to von Wille-brand factor and microparticle formation under high shear stress. Blood 2006; 107(9):3537-3545.
30. Arai S, Shelton JM, Chen M, et al. A role for the apoptosis inhibitory factor AIM/Spalpha/Api6 in atherosclerosis development. Cell Metab 2005; 1(3):201-213.
31. Johnstone RM. Revisiting the road to the discovery of exosomes. Blood Cells Mol Dis 2005; 34(3):214-219.
32. Elliot S, Goldsmith P, Knepper M, Haughey M, Olson B. Urinary excretion of aquaporin-2 in humans: A potential marker of collecting duct responsiveness to vasopressin. J Am Soc Nephrol 1996; 7(3):403-409.
33. Pisitkun T, Shen RF, Knepper MA. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci USA 2004; 101(36):13368-13373.
34. Zhou H, Yuen PS, Pisitkun T, et al. Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery. Kidney Int 2006; 69(8):1471-1476.
35. Zhou H, Pisitkun T, Aponte A, et al. Exosomal Fetuin-A identified by proteomics: A novel urinary biomarker for detecting acute kidney injury. Kidney Int 2006; 70(10):1847-1857.
36. Mallat Z, Benamer H, Hugel B, et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000; 101(8):841-843.
37. van der Zee PM, Biro E, Ko Y, et al. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. Clin Chem 2006; 52(4):657-664.
38. Bernal-Mizrachi L, Jy W, Jimenez JJ, et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J 2003; 145(6):962-970.
39. Bernal-Mizrachi L, Jy W, Fierro C, et al. Endothelial microparticles correlate with high-risk angiographic lesions in acute coronary syndromes. Int J Cardiol 2004; 97(3):439-446.
40. Daniel L, Fakhouri F, Joly D, et al. Increase of circulating neutronphil and platelet microparticles during acute vasculitis and hemodialysis. Kidney Int 2006; 69(8):1416-1423.
41. Chirinos JA, Heresi GA, Velasquez H, et al. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol 2005; 45(9):1467-1471.
42. Preston RA, Jy W, Jimenez JJ, et al. Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 2003; 41(2):211-217.
43. Simak J, Gelderman MP, Yu H, Wright V, Baird AE. Circulating endothelial microparticles in acute ischemic stroke: A link to severity, lesion volume and outcome. J Thromb Haemost 2006; 4(6):1296-1302.
44. Periard D, Boulanger CM, Eyer S, et al. Are circulating endothelial-derived and platelet-derived microparticles a pathogenic factor in the cisplatin-induced stroke? Stroke 2007; 38(5):1636-1638.
45. Leroyer AS, Isobe H, Leseche G, et al. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J Am Coll Cardiol 2007; 49(7):772-777.
46. Ederhy S, Di Angelantonio E, Mallat Z, et al. Levels of circulating procoagulant microparticles in nonvalvular atrial fibrillation. Am J Cardiol 2007; 100(6):989-994.
47. Wang JM, Huang YJ, Wang Y, et al. Increased circulating CD31+/CD42- microparticles are associated with impaired systemic artery elasticity in healthy subjects. Am J Hypertens 2007; 20(9):957-964.
48. Namba M, Tanaka A, Shimada K, et al. Circulating platelet-derived microparticles are associated with atherothrombotic events: A marker for vulnerable blood. Arterioscler Thromb Vasc Biol 2007; 27(1):255-256.
49. Leguyader A, Watanabe R, Berbe J, Boumediene A, Cogne M, Laskar M. Platelet activation after aortic prosthetic valve surgery. Interact Cardiovasc Thorac Surg 2006; 5(1):60-64.
50. Lee YJ, Jy W, Horstman LL, et al. Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. Thromb Res 1993; 72(4):295-304.
51. Sabatier F, Darmon P, Hugel B, et al. Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes 2002; 51(9):2840-2845.
52. Tushuizen ME, Nieuwland R, Rustemeijer C, et al. Elevated endothelial microparticles following consecutive meals are associated with vascular endothelial dysfunction in type 2 diabetes. Diabetes Care 2007; 30(3):728-730.
53. Omoto S, Nomura S, Shouzu A, et al. Significance of platelet-derived microparticles and activated platelets in diabetic nephropathy. Nephron 1999; 81(3):271-277.
54. Ogata N, Imaizumi M, Nomura S, et al. Increased levels of platelet-derived microparticles in patients with diabetic retinopathy. Diabetes Res Clin Pract 2005; 68(3):193-201.
55. Ogata N, Nomura S, Shouzu A, Imaizumi M, Arichi M, Matsumura M. Elevation of monocyte-derived microparticles in patients with diabetic retinopathy. Diabetes Res Clin Pract 2006; 73(3):241-248.
56. Arteaga RB, Chirinos JA, Soriano AO, et al. Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome. Am J Cardiol 2006; 98(1):70-74.
57. Gelderman MP, Schiffmann R, Simak J. Elevated endothelial microparticles in Fabry children decreased after enzyme replacement therapy. Arterioscler Thromb Vasc Biol 2007; 27(7): e138-139.
58. Geisbert TW, Young HA, Jahrling PB, Davis KJ, Kagan E, Hensley LE. Mechanisms underlying coagulation abnormalities in Ebola hemorrhagic fever: Overexpression of tissue factor in primate monocytes/macrophages is a key event. J Infect Dis 2003; 188(11):1618-1629.
59. Chamouard P, Desprez D, Hugel B, et al. Circulating cell-derived microparticles in Crohn's disease. Dig Dis Sci 2005; 50(3):574-580.
60. Ogura H, Tanaka H, Koh T, et al. Enhanced production of endothelial microparticles with increased binding to leukocytes in patients with severe systemic inflammatory response syndrome. J Trauma 2004; 56(4):823-830; discussion 30-31.
61. Soriano AO, Jy W, Chirinos JA, et al. Levels of endothelial and platelet microparticles and their interactions with leukocytes negatively correlate with organ dysfunction and predict mortality in severe sepsis. Crit Care Med 2005; 33(11):2540-2546.
62. Pattanapanyasat K, Gonwong S, Chaichompoo P, et al. Activated platelet-derived microparticles in thalassaemia. Br J Haematol 2007; 136(3): 462-471.
63. Goichot B, Grunebaum L, Desprez D, et al. Circulating procoagulant microparticles in obesity. Diabetes Metab 2006; 32(1):82-85.
64. Pereira J, Alfaro G, Goycoolea M, et al. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state. Thromb Haemost 2006; 95(1):94-99.
65. Jimenez JJ, Jy W, Mauro LM, Horstman LL, Soderland C, Ahn YS. Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation. Br J Haematol 2003; 123(5):896-902.
66. Jimenez JJ, Jy W, Mauro LM, Horstman LL, Ahn YS. Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease. Br J Haematol 2001; 112(1): 81-90.
67. Kelton JG, Warkentin TE, Hayward CP, Murphy WG. Moore JC. Calpain activity in patients with thrombotic thrombocytopenic purpura is associated with platelet microparticles. Blood 1992; 80(9):2246-2251.
68. Simak J, Holada K, Risitano AM, Zivny JH, Young NS, Vostal JG. Elevated circulating endothelial membrane microparticles in paroxysmal nocturnal haemoglobinuria. Br J Haematol 2004; 125(6):804-813.
69. Knijff-Dutmer EA, Koerts J, Nieuwland R, Kalsbeek-Batenburg EM, van de Laar MA. Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis. Arthritis Rheum 2002; 46(6):1498-1503.
70. Pamuk GE, Vural O, Turgut B, Demir M, Umit H, Tezel A. Increased circulating platelet-neutrophil, platelet-monocyte complexes, and platelet activation in patients with ulcerative colitis: a comparative study. Am J Hematol 2006; 81(10):753-759.
71. Esposito K, Ciotola M, Giugliano F, et al. Endothelial microparticles correlate with erectile dysfunction in diabetic men. Int J Impot Res 2007; 19(2):161-166.
72. Tushuizen ME, Nieuwland R, Scheffer PG, Sturk A, Heine RJ, Diamant M. Two consecutive high-fat meals affect endothelial-dependent vasodilation, oxidative stress and cellular microparticles in healthy men. J Thromb Haemost 2006; 4(5):1003-1010.
73. Germain SJ, Sacks GP, Soorana SR, Sargent IL, Redman CW. Systemic inflammatory priming in normal pregnancy and preeclampsia: The role of circulating syncytiotrophoblast microparticles. J Immunol 2007; 178(9):5949-5956.
74. Amabile N, Guerin AP, Leroyer A, et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 2005; 16(11):3381-3388.
75. Hron G, Kollars M, Weber H, et al. Tissue factor-positive microparticles: Cellular origin and association with coagulation activation in patients with colorectal cancer. Thromb Haemost 2007; 97(1):119-123.
76. Minagar A, Jy W, Jimenez JJ, et al. Elevated plasma endothelial microparticles in multiple sclerosis. Neurology 2001; 56(10): 1319-1324.
77. Pihusch V, Rank A, Steber R, et al. Endothelial cell-derived microparticles in allogeneic hematopoietic stem cell recipients. Transplantation 2006; 81(10):1405-1409.
78. Faure V, Dou L, Sabatier F, et al. Elevation of circulating endothelial microparticles in patients with chronic renal failure. J Thromb Haemost 2006; 4(3):566-573.